E. P. Sharapova

A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG

E. P. Sharapova, N. V. Chichasova, N. A. Shostak et al. · Rheumatology Science and Practice · 2014 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG

E. P. Sharapova, N. G. Pravdyuk, L N Denisov · Rheumatology Science and Practice · 2013 · 26 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +8

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY

E. P. Sharapova, E. Strebkova, E. V. Zonova · Rheumatology Science and Practice · 2018 · 14 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +9

Comparative study of the efficacy and safety of Chondroguard® during its combined (intra-articular and intramuscular) and intramuscular injection in patients with knee osteoarthritis

E. P. Sharapova, A. N. Bogdanov, A. A. Bagretsova et al. · Modern Rheumatology Journal · 2018 · 10 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

A multicenter, prospective, randomized trial of the efficacy and safety of Alflutop® in an alternating dosing regimen versus the standard one. Communication 2: Evaluation of the efficacy of the drug in different use regimens

E. P. Sharapova, E. A. Strebkova, V. I. Mazurov · Modern Rheumatology Journal · 2020 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16